Alterity Therapeutics Limited
ATHE
$3.43
-$0.02-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | 0.32% | -25.30% | |||
| Total Revenue | 0.32% | -25.30% | |||
| Cost of Revenue | 0.31% | 57.56% | |||
| Gross Profit | 0.33% | -26.71% | |||
| SG&A Expenses | 0.32% | 140.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.32% | 538.78% | |||
| Total Operating Expenses | 0.32% | 23.55% | |||
| Operating Income | -0.32% | -49.86% | |||
| Income Before Tax | -0.32% | -98.89% | |||
| Income Tax Expenses | 0.50% | -7.80% | |||
| Earnings from Continuing Operations | -0.32% | -97.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | -97.43% | |||
| EBIT | -0.32% | -49.86% | |||
| EBITDA | -0.32% | -50.07% | |||
| EPS Basic | 0.00% | -50.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | -50.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 36.08% | |||
| Average Diluted Shares Outstanding | 0.00% | 36.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||